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Summary
 
Isolation of large numbers of surface IgD
 
1
 
CD38
 
2
 
 naive and surface IgD
 
2
 
CD38
 
2
 
 memory B
cells allowed us to study the intrinsic differences between these two populations. Upon in vitro
culture with IL-2 and IL-10, human CD40–activated memory B cells undergo terminal differ-
entiation into plasma cells more readily than do naive B cells, as they give rise to five- to eight-
fold more plasma cells and three- to fourfold more secreted immunoglobulins. By contrast, na-
ive B cells give rise to a larger number of nondifferentiated B blasts. Saturating concentrations
of CD40 ligand, which fully inhibit naive B cell differentiation, only partially affect that of
memory B cells. The propensity of memory B cells to undergo terminal plasma cell differentia-
tion may explain the extensive extra follicular plasma cell reaction and the limited germinal
center reaction observed in vivo after secondary immunizations, which contrast with primary
responses in carrier-primed animals. This unique feature of memory B cells may confer two
important capacities to the immune system: (
 
a
 
) the rapid generation of a large number of effec-
tor cells to efficiently eliminate the pathogens; and (
 
b
 
) the prevention of the overexpansion and
chronic accumulation of one particular memory B cell clone that would freeze the available
peripheral repertoire.
 
M
 
emory B lymphocytes are mainly generated in the
germinal centers (GCs)
 
1
 
 of secondary lymphoid or-
gans (1–8). Within these structures, proliferating B blasts
can increase the affinity of their surface Igs through somatic
mutation of their Ig variable region genes and positive se-
lection of high affinity mutants (9–16). Isotype switch of
the Igs can also occur during GC reaction (17–19). After leav-
ing the GCs, memory B cells either join the recirculating
pool of lymphocytes, or home to antigen draining sites
such as the marginal zone of the spleen (20). Memory B
cells display several intrinsic differences with naive B cells:
(
 
a
 
) lower threshold for activation, (
 
b
 
) ability to directly
present antigen to helper T cells, and (
 
c
 
) longer life span
(21–27). Although these features of memory B cells are es-
sential for the immune system to make a robust secondary
antibody response, they may lead to an overexpansion of a
particular memory B cell clone, which would overload the
immune system during chronic infections or antigenic
stimulations (26). Several hypotheses can be put forward to
explain how the immune system controls the size of mem-
ory cell clones: (
 
a
 
) decreasing potential hypothesis: memory
(T and B) cells generated after each round of stimulation
acquire a decreased potential to generate new memory cells
and an increased potential to undergo terminal differentia-
tion into effector cells (26, 27), (
 
b
 
) growth factor/costimu-
latory signal starvation hypothesis: at the late stage of im-
mune responses, the clonally expanded memory blasts (T
and B) undergo apoptosis in the absence of growth factors/
costimulating molecules (26, 27), and (
 
c
 
) hypothesis of Fas
ligand–mediated apoptosis: T cells can undergo autocrine
Fas ligand–mediated apoptosis (28–30), and B cells can be
sensitized to Fas ligand–mediated apoptosis by CD40 trig-
gering (31).
Recently, large amounts of human memory B cells have
been purified from human tonsils and blood, based on their
IgD
 
2
 
CD38
 
2
 
 or IgM
 
1
 
IgD
 
2
 
 or IgA1
 
1
 
 phenotypes (32–36).
These cells contained somatically mutated IgV genes, an
indication of their germinal center origin. The isolation of
these memory B cells allowed us to directly test the de-
creasing potential hypothesis by culturing memory and na-
ive B cells in vitro. Herein, we describe a novel important
feature of memory B cells: their bias towards terminal
plasma cell differentiation.
 
Materials and Methods
 
Antibodies and Reagents.
 
The mouse mAbs used for the phe-
notypic studies were FITC-conjugated anti-CD20 (IOB20; Im-
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell receptor; CD40L, CD40
ligand; GC, germinal center; PC, plasma cell.
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munotech, Marseille, France) and PE-conjugated anti-CD38
(Leu17; Becton Dickinson Monoclonal Center, Mountain View,
CA). Antibodies used for cell purification and cell culture were anti-
CD4 (Q4120) and biotinylated anti-IgD (HJ9) purchased from
Sigma Chemical Co. (St. Louis, MO), anti-CD38 (T16), anti-Ig
 
k
 
(6E1), and anti-Ig
 
l
 
 (C4) purchased from Immunotech, and anti-
CD2, -CD3, -CD8 ascites produced in our own laboratory using
the OKT hybridomas obtained from American Type Culture
Collection (Rockville, MD). Antibodies used for immunoenzy-
matic stainings are described in the corresponding section. Anti-
CD40 ligand (LL48) -blocking mAb and CD40 ligand (CD40L)
-transfected murine fibroblasts were produced in our laboratory (31).
Recombinant human IL-2 was purchased from Amgen Bio-
logicals (Thousand Oaks, CA) and recombinant human IL-10 is
from Schering-Plough Research Institute (Kenilworth, NJ). IL-2
was used at 10 U/ml and IL-10 at 100 ng/ml in cultures.
Giemsa-Gurr and Mayer’s hematoxylin staining solutions were
purchased from BDH Laboratory Supplies (Poole, England) and
Sigma Chemical Co., respectively.
 
Purification of B Cell Populations.
 
Naive and memory B cells
were purified from human tonsils obtained from children under-
going routine tonsillectomy, as previously described (33). In brief,
tonsils were finely minced in RPMI 1640 (GIBCO BRL, Paisley,
UK). Cell suspension was washed twice and T cells were depleted
by sheep RBC rosetting and centrifugation at room temperature
on ditrizoate-ficoll (density 
 
5
 
 1,077; Eurobio, Les Ulis, France).
B cells were then incubated with biotinylated anti–human IgD
antibodies. For naive cell purification, two rounds of positive selec-
tion were performed with a magnetic activated cell sorter (MACS
 
Ò
 
;
Miltenyi Biotec, Bergisch Gladbach, Germany). For memory cell
preparation, two rounds of negative magnetic beads depletion
(Streptavidin-coated Dynabeads; Dynal, Oslo, Norway) were per-
formed. Both resulting IgD
 
1
 
 and IgD
 
2
 
 populations were further
depleted of T cells and CD38
 
1
 
 (i.e., GC) B cells by incubation
with anti-CD2, -CD3, -CD4, -CD8, and -CD38 antibodies fol-
lowed by two rounds of depletion with anti–mouse IgG-coated
magnetic beads (Dynal). This procedure lead to 98–99.5% pure na-
ive and 95–99.5% pure memory B cell populations.
 
Proliferation Assays.
 
For DNA synthesis, 2.5 
 
3
 
 10
 
4
 
 B cells
were cultured together with 5 
 
3
 
 10
 
3
 
, 75 Gy–irradiated, CD40L–
transfected fibroblasts in 200 
 
m
 
l Iscove medium (GIBCO) com-
plemented with 5% FCS (GIBCO) for 12 d in the presence of
IL-2 and IL-10. DNA synthesis was assessed by incubation with 1
 
m
 
Ci of tritiated thymidine (Amersham, Les Ulis, France) during
the last 8 h of culture. For cellular expansion, 1.5 
 
3
 
 10
 
5
 
 B cells
were cultured with 5 
 
3
 
 10
 
4
 
 CD40L–transfected fibroblasts for 12
d in the presence of IL-2 and IL-10. Cells were harvested and
counted in tripan blue (GIBCO) to exclude dead cells.
 
Two-step Cell Cultures.
 
1.5–2 
 
3
 
 10
 
7
 
 purified naive or mem-
ory B cells were cultured for 3 d in 20 ml Iscove medium com-
plemented with 5% FCS in the presence of IL-2, IL-10, and
CD40L–transfected fibroblasts (5:1, B cells/fibroblast). Cells were
then harvested, washed, and recultured with or without CD40L.
In another set of experiments, anti-Ig
 
l
 
 and Ig
 
k
 
 antibodies were
used to trigger B cell receptor (BCR) at 2 
 
m
 
g/ml final concentra-
tion. Secondary cultures consisted of 1.5 
 
3
 
 10
 
5
 
 B cells in 1 ml Is-
cove medium containing IL-2 and IL-10, together with 5 
 
3
 
 10
 
4
 
irradiated murine fibroblasts. Murine fibroblasts were either
CD40L–transfected cells or nontransfected cells together with
anti-CD40L–blocking antibody at 2 
 
m
 
g/ml to block the signals
given by CD40L–transfected cells that could have been harvested
from the primary cultures. All secondary cultures were done in
triplicate. After 4 d, cultures were harvested, supernatants frozen
for antibody titer assays, and cells kept for analysis.
 
Quantitation of CD40L Molecules on Murine Fibroblasts.
 
The
number of CD40L molecules expressed on transfected fibroblasts
was estimated using a Qifikit
 
Ò
 
 system (Dako, Goldstrup, Den-
mark) immediately before establishment of cultures. In brief, cells
were incubated at saturation with either an anti-CD40L mAb
(IgG
 
1
 
 isotype) or a nonrelevant control-matched antibody for 20
min on ice. After two washes, they were incubated with FITC-
conjugated sheep anti–mouse immunoglobulins at the same time
as different beads suspensions, coated with a known number of
mouse Igs. Cells and beads were then analyzed using a FACScan
 
Ò
 
(Becton Dickinson, Sunnyvale, CA). Means of fluorescence in-
tensity were then plotted against the number of mouse Igs on
beads and linear regression was calculated (r
 
2
 
 
 
>
 
0.998 in all exper-
iments). The number of recognized molecules (CD40L) on stained
fibroblasts was calculated using the linear regression and the fluo-
rescence intensity of these cells, after taking account of the fluo-
rescence of the cells stained with the control-matched antibody.
 
Cell Cultures with Progressive Triggering of CD40.
 
To assess the
effect of progressive triggering of CD40 antigen on naive and
memory B cells, a second two-step culture was established. Cells
were grown in primary cultures as in the previous two-step cul-
ture system. After 3 d, cells were recultured under seven different
conditions. As the number of CD40L molecules on transfected fi-
broblasts varies from one experiment to another, a fixed cell ratio,
rather than a fixed number of molecules, was chosen to avoid dif-
ferences in the fibroblast feeder effects. Therefore, 1.5 
 
3
 
 10
 
5
 
 B
cells were cultured for 4 d in 1 ml Iscove medium containing
IL-2 and IL-10, together with 5 
 
3
 
 10
 
4
 
 irradiated fibroblasts. One
culture condition was established with CD40L-transfected cells
whose CD40L molecules number has been determined. These
cells are then diluted with nontransfected irradiated fibroblasts for
other culture conditions at the ratios of 1/2, 1/4, 1/8, and 1/16.
Two other cultures were also set using parental cells, with or
without anti-CD40L antibody at 2 
 
m
 
g/ml. All secondary cultures
were set in triplicates and designed as the number of CD40L mol-
ecules present in the culture per B cell.
 
Ig Secretion Assays.
 
IgA, IgG, and IgM concentrations in cul-
ture supernatants were measured using ELISA. Total Ig levels are
given as the summation of these values.
 
Cell Sorting.
 
Naive and memory cells were cultured for 3 d in
the presence of IL-2, IL-10, and CD40L-transfected fibroblasts.
They were then harvested and recultured for an additional 4 d
with IL-2, IL-10, and parental fibroblasts. After harvesting, debris
and dead cells were depleted from the cultures by centrifugation
on ditrizoate-ficoll (Eurobio). Cells were then stained with
FITC-conjugated anti-CD20 and PE-conjugated anti-CD38 an-
tibodies. Both CD20
 
2
 
/low
 
CD38
 
high
 
 and CD20
 
1
 
CD38
 
2
 
 popula-
tions were sorted using a FACStar
 
Ò
 
 (Becton Dickinson Immuno-
cytometry Systems, San Jose, CA).
 
Giemsa and Immunoenzymatic Stainings.
 
7 
 
3
 
 10
 
4
 
 sorted cells
were cytocentrifuged on microscope slides. Some slides were
stained with Giemsa-Gurr solution, whereas others were kept for
immunoenzymatic staining. Human Igs were revealed by anti–
human 
 
k
 
 and 
 
l
 
 light chain antibodies (A8B5 and N10/2 clones,
respectively, IgG
 
1
 
 isotypes; Dako), whereas IgM isotype Igs were
revealed by anti–human IgM mAb (145-8, IgG
 
1
 
 isotype; Becton
Dickinson Monoclonal Center). Enzymatic activity was devel-
oped with Fast Red substrate (Dako). All immunoenzymatically
colored slides were lightly counterstained with Mayer’s hematox-
ylin solution. 
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Results
 
Memory B Cells Undergo Prompt Differentiation into Plasma
Cells upon Activation.
 
Using a two-step culture system, we
previously demonstrated that continuous triggering of CD40
antigen on GC cells inhibits their terminal differentiation
into plasma cells (PC; 37). To determine the influence of
CD40L on the capacity of memory and naive B cells to gen-
erate PCs, similar culture conditions were used. Both pop-
ulations were cultured for 3 d over CD40L-transfected fi-
broblasts in the presence of IL-2 and IL-10. Activated B
cell blasts were then recultured for 4 d with nontransfected
fibroblasts, IL-2, IL-10, and an anti-CD40L–blocking anti-
body to block the CD40L-transfected fibroblasts carried
over from the primary culture. Although naive B cells yielded
16.4 
 
6
 
 6.6% CD20
 
2
 
/low
 
CD38
 
high
 
 plasma cells (mean 
 
6
 
SD, 
 
n
 
 
 
5
 
 7; Fig. 1 
 
B
 
; Table 1), memory B cells yielded
62.4 
 
6
 
 11.9% plasma cells (mean 
 
6
 
 SD, 
 
n
 
 
 
5
 
 4; Fig. 1 
 
D
 
;
Table 1). Accordingly, naive B cells yielded three times
more nondifferentiated CD20
 
1
 
CD38
 
low
 
 B blasts than did
memory cells. Addition of CD40L during the secondary
culture (Fig. 1, 
 
A
 
 and 
 
C
 
) considerably inhibited the plasma
cell differentiation of B cell blasts, generated from both na-
ive and memory cells (Table 1).
FACS
 
Ò
 
-sorted CD20
 
2
 
/low
 
CD38
 
high
 
 cells generated from
both naive and memory B blasts display the morphology of
terminally differentiated PCs (Fig. 2 
 
A
 
), as well as an in-
tense Ig
 
k
 
 and Ig
 
l
 
 light chain staining (Fig. 2 
 
C
 
). In con-
trast, CD20
 
1
 
CD38
 
low
 
 populations display the morphology
of blasts with a weak surface Ig expression (Fig. 2, 
 
B
 
 and
 
D
 
). Although 50% of plasma cells generated from naive B
cells contain intracytoplasmic IgM (Fig. 2 
 
E
 
), only 20% of
plasma cells generated from memory B cells expressed IgM
(Fig. 2 
 
F
 
).
 
High Concentrations of CD40L Do Not Completely Block the
Terminal Differentiation of Memory B Cells.
 
To further under-
stand the propensity of memory B cells to undergo plasma
cell differentiation, secondary cultures of naive and mem-
ory blasts were set up in the presence of increasing density
of CD40L. For that purpose, absolute numbers of CD40L
molecules per fibroblast were estimated using quantitative
flow cytometry and CD40L-transfected fibroblasts were
gradually diluted with their parental cells (see Material and
Methods). As shown in Fig. 3 
 
A
 
, increased CD40 ligation
of memory cells results in a decreased production of plasma
cells and a concommitant increase of B blasts (Fig. 3 
 
B
 
). In
fact, there is a linear correlation between the log (1/
CD40L available per memory blast) and the percentage of
generated plasma cells (r
 
2 5 0.945, 0.966, and 0.983 from
three experiments). Note that CD40L-transfected fibro-
blasts were indeed carried over from the primary cultures,
as the addition of anti-CD40L antibody to the cultures
with nontransfected fibroblasts further enhanced the plasma
cell generation. As shown in Fig. 3 C, in the absence of
CD40L in the secondary culture, memory cells can gener-
ate up to eight times more PCs than do naive cells. Note
that very high amounts of CD40L molecules in the sec-
ondary cultures do not completely inhibit the generation of
PCs from memory cells, since up to 2 3 105 CD40L mole-
cules/B blast led to the generation of 3.6 3 105 PCs from
an initial input of 1.5 3 105 blasts (Fig. 3 C).
Figure 1. Naive and memory cells differentiation at the end of sec-
ondary cultures, followed by CD20 and CD38 expression. PCs are
CD202/lowCD38high and nondifferentiated B blasts (BLASTS) are
CD201CD38low (37). (A) Naive B cells cultured with IL-2 and IL-10
over CD40L-transfected L cells. (B) Naive B cells cultured with IL-2 and
IL-10 over parental nontransfected L cells together with an anti-CD40L–
blocking antibody at 2 mg/ml. (C) Memory B cells cultured with IL-2
and IL-10 over CD40L-transfected L cells. (D) Memory B cells cultured
IL-2 and IL-10 over nontransfected L cells together with an anti-CD40L–
blocking antibody at 2 mg/ml.
Table 1. Memory B Cells Promptly Differentiate into PC
Percentage of CD202/lowCD38high
cells generated from
Secondary cultures Naive cells Memory cells
CD40L-transfected
fibroblasts 3.7 6 1.8 [1.1–6.7] 23.8 6 7.8 [15–31]
Parental fibroblasts
1 anti-CD40L
mAb 16.4 6 6.6 [5.4–25] 62.4 6 11.9 [50.8–79]
Mean, standard deviation, and range (brackets) of percentages of
CD202/low CD38high cells generated from naive and memory B cells
from seven and four experiments, respectively. Cells were cultured for
3 d in the presence of IL-2, IL-10, and CD40L-transfected fibroblasts
before being seeded for 4 d in the secondary cultures together with IL-2,
IL-10, and fibroblasts. The fibroblasts used in secondary cultures are
listed in the table.934 Human Memory B Cell Differentiation
Increasing the number of CD40L molecules available in
the cultures not only inhibited the plasma cell generation,
but also the secretion of Igs (Fig. 4 A). Furthermore, in all
culture conditions, memory B cells produced more total Igs
than naive B cells (Fig. 4 A). With regard to secreted iso-
type, although naive and memory B cells produced compa-
rable levels of IgM (Fig. 4 D), memory cells, as expected,
produced considerably more IgG and IgA (Fig. 4, B and C).
Naive and Memory B Cells Proliferate Equally Well. We then
questioned whether the poor differentiation capacity of na-
ive B cells, as compared to that of memory B cells, may in-
deed reflect a reduced activation and proliferation capacity.
Thus, purified naive and memory B cells were cultured
over CD40L-transfected fibroblasts with IL-2 and IL-10,
and proliferation was assessed by measuring thymidine in-
corporation, as well as viable cell numbers. As shown in
Fig. 5, naive B cells proliferate at least as much as memory
B cells do.
Figure 2. Morphology and intracellular Ig content. Giemsa staining of sorted CD202/lowCD38high PC (A, original magnification: 1,000) and
CD201CD38low B blasts (B, original magnification: 1,000). Red anti-Igk 1 l light chain staining of sorted CD202/lowCD38high PCs (C, original magni-
fication: 1,000) and CD201CD38low B blasts (D, original magnification: 1,000). Red anti-IgM staining of sorted CD202/lowCD38high PCs derived from
naive B cells (E, original magnification: 400) and from memory B cells (F, original magnification: 400).935 Arpin et al.
Memory, but Not Naive, B Cells Undergo Rapid PC Differ-
entiation in Cultures even after Anti-BCR Triggering. Anti-
Igs were shown to prevent B cell differentiation (38). Since
naive B cells, but not memory B cells, were isolated by
positive selection using anti-IgD, we questioned whether
the difference in the differentiation capacity between naive
and memory B cells could be due to the BCR triggering.
Accordingly, in the first 3 d of primary cultures, 2 mg/ml of
Figure 3. CD40L inhibits B cell differentiation during secondary cultures in a dose-dependent fashion. (A) Percentages of CD202/lowCD38high PCs de-
rived from naive (closed circles) and memory (open circles) B cells. (B) Percentages of CD201CD38low nondifferentiated B blasts derived from naive (closed cir-
cles) and memory (open circles) B cells. (C) Total numbers of CD202/lowCD38high PCs derived from naive (closed circles) and memory (open circles) B cells.
The number of CD40L molecules per B cell in secondary cultures was measured and used as x-axis (a negative value artificially represents cultures with
parental fibroblasts in the presence of a blocking antibody to CD40L at 2 mg/ml). Cell input was 1.5 3 105 at the beginning of secondary cultures. Each
circle represents an individual value. Mean values are linked (plain and dotted lines represent naive and memory cell cultures, respectively). Standard de-
viations are vertical bars.
Figure 4. CD40L inhibits Ig
production during secondary
cultures in a dose-dependent
fashion. The culture conditions
are the same as described in Fig.
3. (A) Total IgG 1 IgA 1 IgM
production from 106 cells of na-
ive (closed circles) and of memory
B cell cultures (open circles). (B) IgA
production. (C) IgG produc-
tion. (D) IgM production. Each
circle (closed and open corre-
spond to naive and memory cell
cultures, respectively) represents
an individual value. Mean values
are linked (plain and dotted lines
represent naive and memory cell
cultures, respectively). Standard
deviations are vertical bars.936 Human Memory B Cell Differentiation
anti-Igk and 2 mg/ml of anti-Igl antibodies were added
into the cultures in the presence of CD40L, IL-2, and IL-10.
At the end of the culture, cells were washed and seeded in
a 4 d secondary culture with IL-2, IL-10, and different
concentrations of CD40L. Fig. 6 shows that in the presence
of three different CD40L concentrations (9.6 3 104/cell,
4.8 3 104/cell, no CD40L), 3, 6, and 13% of CD381
CD202 plasma cells were generated from the naive B cells.
In the same culture conditions, 21, 29, and 43% of CD381
CD202 plasma cells were generated from the memory B
cells. This experiment indicates that memory B cells, but
not naive B cells, preferentially undergo plasma cell differ-
entiation even after BCR triggering.
Discussion
This paper describes the striking differentiation ability of
memory versus that of naive B cells. This correlates with
previous histophysiological observations in vivo showing
that secondary antigenic challenge in carrier-primed rats
leads to a massive extrafollicular PC reaction and a poor
follicular GC reaction in the spleen. In contrast, only small
extrafollicular PC reactions, but large GC reactions develop
upon primary immunization (Fig. 7; 39, 40). Likewise, in
mice infected with reoviruses, adoptively transferred mem-
ory B cells give rise to a large extrafollicular PC reaction,
but a small GC reaction; in contrast, transferred naive cells
generate a large GC reaction (41). Thus, the differences in
the capacity of memory versus naive B cells to differentiate
is an intrinsic property of the B cells, rather than of the mi-
croenvironments. The propensity of memory B cells to un-
dergo rapid differentiation into effector cells may confer
two important properties to the immune system. First, it al-
lows the rapid generation of large numbers of effector cells,
whose products (antibodies) efficiently eliminate patho-
gens. This novel feature of memory B cells, together with
their low threshold for activation, and their ability to home
to the antigen draining sites and to directly present antigen
to T cells, may all contribute to the velocity of secondary
antibody responses. Second, it prevents the overexpansion
and accumulation of a particular memory B cell clone that
would otherwise overload the immune system and freeze
the available Ig repertoire (26). Since PCs have a relatively
short lifespan and do not proliferate in response to further
stimulations (42–44), the majority of memory B cells will
undergo clonal exhaustion by differentiating into effector
cells during secondary immune responses. Interestingly, T
memory cells show a similar tendency not to expand and
overload the whole immune system, as towards the end of
a primary immune response specific T blasts are rapidly
eliminated (45–48).
The finding that CD40L inhibits the differentiation of
both activated memory and naive B cells, complements the
previous observations made with GC B cells (37) or total B
cells isolated from blood and tonsils (49, 50). Thus, CD40L
represents a differentiation suppressor during not only the
Figure 5. Naive and memory
B cells undergo comparable pro-
liferation and expansion during
12 d of cultures with IL-2 and
IL-10 over CD40L-transfected L
cells. (A) [3H]thymidine uptake
by cultured naive (closed circles) and
memory (open circles) B cells. (B)
Cell numbers of cultured naive
(closed  circles) and memory (open cir-
cles) B cells. Initial cell inputs were
2.5 3 104 for [3H]thymidine up-
take and 1.5 3 105 for the viable
cell numbers.
Figure 6. Memory, but not naive, B cells preferentially undergo plasma
cell differentiation even after BCR triggering. Naive and memory B cells
were cultured for 3 d with anti-Igk and anti-Igl antibodies, together with
IL-2, IL-10, and CD40L. After washing, cells were recultured with IL-2,
IL-10, and different concentrations of CD40L for 4 d. (A) CD381CD202
plasma cells and CD38lowCD201 undifferentiated B cells generated from
naive B cells. (B) CD381CD202 plasma cells and CD38lowCD201 undif-
ferentiated B cells generated from memory B cells. This is one representa-
tive of two experiments.937 Arpin et al.
Figure 7. Memory B cells are biased towards terminal plasma cell differentiation in vivo and in vitro. Naive B cells predominantly give rise to germinal
center reaction within a rat spleen after primary immunization with DNP-KLH in KLH-primed animals (A original magnification: 40; B original magni-
fication: 200). The rats were given BrdU in their drinking water for 48 h before they were killed. Red stains BrdU, blue stains DNP-binding cells, brown
stains total B cells. MZ, marginal zone; PALS, periarteriolar lymphoid sheath. Consistent with this in vivo finding, human naive B cells predominantly
give rise to proliferating B blasts upon activation in vitro (C). Memory B cells predominantly give rise to plasma cell reaction along the outer edges of the
periarteriolar lymphoid sheath and within the red pulp of a rat spleen after 2 d of secondary immunization with DNP-KLH (D and E). The rats have re-
ceived BrdU in their drinking water for 48 h before killing. DNP-specific plasma blasts are cells with strong blue cytoplasmic staining. Consistent with
this in vivo finding, human memory B cells predominantly give rise to plasma cells upon activation in vitro (F). The figures on immunohistology are de-
rived from Y.-J. Liu and I.C.M. MacLennan (40).938 Human Memory B Cell Differentiation
GC, but also the extrafollicular reactions (51). Indeed,
CD40L-expressing T cells have been reported by immuno-
histology, both within the GCs and the extrafollicular T
zones (52–54).
Although CD40L inhibits the PC differentiation of na-
ive, GC, and memory B cells, a fraction of the memory cell
subset seems to be resistant to this effect. Differential effects
of CD40L on mature B cell subsets have already been no-
ticed. For instance, CD40 triggering is an important sur-
vival but a minor proliferative signal for GC cells (55–57),
whereas it provides a strong and long-term proliferative
signal to resting naive and memory B cells (58–61). The
molecular mechanisms underlying the propensity of mem-
ory B cells to undergo terminal differentiation are still un-
known. CD40 triggering on human GCs and resting ma-
ture B cells results in the activation of different protein
kinases (62, 63). Further comparative studies of CD40 sig-
naling pathways in naive, GC, and memory B cells should
now be carried on to explain how mature B cells change
their responses to CD40 triggering at different stages of
their immunopoiesis.
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